C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia
Metrics: PDF 1331 views | HTML 1454 views | ?
James M. Hughes1, Ivano Legnini1, Beatrice Salvatori1,6, Silvia Masciarelli2, Marcella Marchioni3, Francesco Fazi2, Mariangela Morlando1, Irene Bozzoni1,3,4,5, Alessandro Fatica1
1Department of Biology and Biotechnology “C. Darwin”, Sapienza University of Rome, Rome, Italy
2Department of Anatomical, Histological, Forensic & Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy
3Institute of Biology, Molecular Medicine and Nanobiotechnology, CNR, Sapienza University of Rome, Rome, Italy
4Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy
5Institute Pasteur Fondazione Cenci-Bolognetti, Sapienza University of Rome, Rome, Italy
6Department of Systems Biology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA
Alessandro Fatica, e-mail: email@example.com
Keywords: long non-coding RNA, acute myeloid leukemia, CEBPA, UCA1
Received: February 05, 2015 Accepted: May 13, 2015 Published: May 25, 2015
Accumulating evidences indicate that different long non-coding RNAs (lncRNAs) might play a relevant role in tumorigenesis, with their expression and function already associated to cancer development and progression. CCAAT/enhancer-binding protein-α (CEBPA) is a critical regulator of myeloid differentiation whose inactivation contributes to the development of acute myeloid leukemia (AML). Mutations in C/EBPα occur in around 10% of AML cases, leading to the expression of a 30-kDa dominant negative isoform (C/EBPα-p30). In this study, we identified the oncogenic urothelial carcinoma associated 1 (UCA1) lncRNA as a novel target of the C/EBPα-p30. We show that wild-type C/EBPα and C/EBPα-p30 isoform can bind the UCA1 promoter but have opposite effects on UCA1 expression. While wild-type C/EBPα represses, C/EBPα-p30 can induce UCA1 transcription. Notably, we also show that UCA1 expression increases in cytogenetically normal AML cases carrying biallelic CEBPA mutations. Furthermore, we demonstrate that UCA1 sustains proliferation of AML cells by repressing the expression of the cell cycle regulator p27kip1. Thus, we identified, for the first time, an oncogenic lncRNA functioning in concert with the dominant negative isoform of C/EBPα in AML.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.